{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:32:31Z","timestamp":1794209551150,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the independent risk factors for the first recurrence after endovascular management in patients with Budd\u2013Chiari syndrome (BCS), and to establish a prediction model for predicting recurrence in target patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BCS patients who underwent endovascular treatment in the Affiliated Hospital of Xuzhou Medical University from January 2010 to December 2015 were retrospectively examined, with their clinical, laboratory test, and imaging data collected and analyzed. Independent risk factors for recurrence were identified, and a prediction model was established and validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 450 patients met the filtering criteria, and 102 recurred during the follow-up. The median follow-up time was 87\u00a0months, ranging from 1 to 137\u00a0months. The 1-, 3-, 5- and 10-year cumulative recurrence rate was 9.11% (6.41\u201311.73%), 17.35% (13.77\u201320.78%), 20.10% (16.30\u201323.72%), and 23.06% (18.86\u201327.04%), respectively. Liver cirrhosis, ascites, thrombosis, and all the main intrahepatic drainage veins obstructed (obstructed HV\u2009+\u2009AHV) are independent risk factors, while age is an independent protective factor. The prediction model was named MRBET. Based on the model, the risk score of each patient equals (\u22120.385981 * Age\/10)\u2009+\u2009(0.0404184 * PT)\u2009+\u2009(0.0943423 * CRE\/10)\u2009+\u2009(0.0157053 * LDH\/10)\u2009+\u2009(0.592179 * LC)\u2009+\u2009(0.896034 * Ascites)\u2009+\u2009(0.691346 * Thrombosis)\u2009+\u2009(0.886741 * obstructed HV\u2009+\u2009AHV), and those in the high-risk group (risk score\u2009\u2265\u20091.57) were more likely to recur than those in the low-risk group (HR\u2009=\u20096.911,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The MRBET model is also available as a web tool at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/mrbet.shinyapps.io\/dynnomapp\">https:\/\/mrbet.shinyapps.io\/dynnomapp<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Liver cirrhosis, ascites, thrombosis, and obstructed HV\u2009+\u2009AHV are independent risk factors for the first recurrence; age is an independent protective factor. The prediction model can effectively and conveniently predict the risk of recurrence and screen out patients at a high recurrence risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-022-10464-y","type":"journal-article","created":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T23:13:19Z","timestamp":1672009999000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Establishment and validation of a prediction model for the first recurrence of Budd\u2013Chiari syndrome after endovascular treatment: a large sample size, single-center retrospective study"],"prefix":"10.1007","volume":"17","author":[{"given":"Zhongkai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoheng","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"issue":"3","key":"10464_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","volume":"38","author":"HL Janssen","year":"2003","unstructured":"Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38(3):364\u2013371","journal-title":"J Hepatol"},{"issue":"4","key":"10464_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.clinre.2020.03.015","volume":"44","author":"A Coilly","year":"2020","unstructured":"Coilly A, Potier P, Brou\u00e9 P, et al. Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2020;44(4):420\u2013425","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10464_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","volume":"151","author":"S Darwish Murad","year":"2009","unstructured":"Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167\u2013175","journal-title":"Ann Intern Med"},{"issue":"23","key":"10464_CR4","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMra063728","volume":"355","author":"PJ Campbell","year":"2006","unstructured":"Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006;355(23):2452\u20132466","journal-title":"N Engl J Med"},{"issue":"11\u201312","key":"10464_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/apt.13815","volume":"44","author":"X Qi","year":"2016","unstructured":"Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44(11\u201312):1152\u20131167","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10464_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jgh.12379","volume":"29","author":"H Wang","year":"2014","unstructured":"Wang H, Sun G, Zhang P, et al. JAK2 V617F mutation and 46\/1 haplotype in Chinese Budd-Chiari syndrome patients. J Gastroenterol Hepatol. 2014;29(1):208\u2013214","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10464_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/hep.20064","volume":"39","author":"S Darwish Murad","year":"2004","unstructured":"Darwish Murad S, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39(2):500\u2013508","journal-title":"Hepatology"},{"issue":"9","key":"10464_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00270-019-02267-w","volume":"42","author":"DL Cheng","year":"2019","unstructured":"Cheng DL, Xu H, et al. Interventional treatment strategy for primary Budd-Chiari syndrome with both inferior vena cava and hepatic vein involvement: patients from two centers in China. Cardiovasc Intervent Radiol. 2019;42(9):1311\u20131321","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10464_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00270-014-0980-4","volume":"38","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Huang Q, Shen B, Sun J, Wang X, Liu H. Efficacy and safety of endovascular intervention for the management of primary entire-inferior vena cava occlusion. Cardiovasc Intervent Radiol. 2015;38(3):665\u2013671","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"10464_CR10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.14309\/ajg.0000000000001273","volume":"116","author":"PJ Thuluvath","year":"2021","unstructured":"Thuluvath PJ, Alukal JJ, Zhang T. A scoring model to predict in-hospital mortality in patients with Budd-Chiari syndrome. Am J Gastroenterol. 2021;116(9):1905\u20131912","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10464_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-021-10189-4","volume":"15","author":"A Shukla","year":"2021","unstructured":"Shukla A, Shreshtha A, Mukund A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2021;15(3):531\u2013567","journal-title":"Hepatol Int"},{"issue":"2","key":"10464_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1148\/radiol.12120856","volume":"266","author":"G Han","year":"2013","unstructured":"Han G, Qi X, Zhang W, He C, Yin Z, Wang J, et al. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology. 2013;266(2):657\u2013667","journal-title":"Radiology"},{"issue":"2","key":"10464_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.surg.2009.06.004","volume":"146","author":"J Hanaoka","year":"2009","unstructured":"Hanaoka J, Shimada M, Uchiyama H, et al. A simple formula to calculate the liver drainage volume of the accessory right hepatic vein using its diameter alone. Surgery. 2009;146(2):264\u2013268","journal-title":"Surgery"},{"issue":"6","key":"10464_CR14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2214\/ajr.181.6.1811641","volume":"181","author":"X Bargall\u00f3","year":"2003","unstructured":"Bargall\u00f3 X, Gilabert R, Nicolau C, Garc\u00eda-Pag\u00e1n JC, Bosch J, Br\u00fa C. Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome. AJR Am J Roentgenol. 2003;181(6):1641\u20131645","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10464_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u2013649","journal-title":"Br J Surg"},{"issue":"4","key":"10464_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864\u2013871","journal-title":"Hepatology"},{"issue":"1","key":"10464_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hep.510300125","volume":"30","author":"G Zeitoun","year":"1999","unstructured":"Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30(1):84\u201389","journal-title":"Hepatology"},{"issue":"6","key":"10464_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/jgh.12140","volume":"28","author":"D Cheng","year":"2013","unstructured":"Cheng D, Xu H, Lu ZJ, et al. Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: a single-center study. J Gastroenterol Hepatol. 2013;28(6):1061\u20131067","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10464_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jgh.13025","volume":"31","author":"PX Ding","year":"2016","unstructured":"Ding PX, Zhang SJ, Li Z, et al. Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome. J Gastroenterol Hepatol. 2016;31(1):222\u2013228","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10464_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00261-014-0240-8","volume":"40","author":"F Zhang","year":"2015","unstructured":"Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd-Chiari syndrome: systematic review and meta-analysis. Abdom Imaging. 2015;40(3):601\u2013608","journal-title":"Abdom Imaging"},{"issue":"4","key":"10464_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","volume":"39","author":"P Langlet","year":"2003","unstructured":"Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39(4):496\u2013501","journal-title":"J Hepatol"},{"issue":"3","key":"10464_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","volume":"135","author":"JC Garcia-Pag\u00e1n","year":"2008","unstructured":"Garcia-Pag\u00e1n JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology. 2008;135(3):808\u2013815","journal-title":"Gastroenterology"},{"issue":"11","key":"10464_CR23","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/apt.13604","volume":"43","author":"DM Shalimar","year":"2016","unstructured":"Shalimar DM, Kumar A, Kedia S, et al. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther. 2016;43(11):1154\u20131167","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10464_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12072-015-9676-3","volume":"10","author":"YF Cui","year":"2016","unstructured":"Cui YF, Fu YF, Li DC, et al. Percutaneous recanalization for hepatic vein-type Budd-Chiari syndrome: long-term patency and survival. Hepatol Int. 2016;10(2):363\u2013369","journal-title":"Hepatol Int"},{"issue":"5","key":"10464_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.clinre.2014.12.010","volume":"39","author":"X Gao","year":"2015","unstructured":"Gao X, Gui E, Lu Z, et al. Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2015;39(5):620\u2013626","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"10464_CR26","first-page":"590","volume":"51","author":"L Wang","year":"2013","unstructured":"Wang L, Zu MH, Gu YM, et al. Budd-Chiari syndrome in children and adolescents: therapeutic radiological intervention. Chin J Pediatrics. 2013;51(8):590\u2013594","journal-title":"Chin J Pediatrics"},{"issue":"3","key":"10464_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00330-016-4482-4","volume":"27","author":"WD Li","year":"2017","unstructured":"Li WD, Yu HY, Qian AM, et al. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: a retrospective analysis of a large cohort. Eur Radiol. 2017;27(3):1227\u20131237","journal-title":"Eur Radiol"},{"issue":"1","key":"10464_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1708538117718638","volume":"26","author":"G Li","year":"2018","unstructured":"Li G, Huang Y, Tang S, et al. A single-center retrospective study: clinical features of different types of Budd-Chiari syndrome in Chinese patients in the Hubei area. Vascular. 2018;26(1):80\u201389","journal-title":"Vascular"},{"issue":"5","key":"10464_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/apt.15137","volume":"49","author":"F Nery","year":"2019","unstructured":"Nery F, Correia S, Macedo C, et al. Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study. Aliment Pharmacol Ther. 2019;49(5):582\u2013588","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10464_CR30","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","volume":"67","author":"R Carnevale","year":"2017","unstructured":"Carnevale R, Raparelli V, Nocella C, et al. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells Implications for hypercoagulability in cirrhosis. J Hepatol. 2017;67(5):950\u2013956","journal-title":"J Hepatol"},{"issue":"1","key":"10464_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","volume":"157","author":"JG O'Leary","year":"2019","unstructured":"O\u2019Leary JG, Greenberg CS, Patton HM, et al. AGA Clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34-43.e1","journal-title":"Gastroenterology"},{"issue":"2","key":"10464_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0038-1676954","volume":"119","author":"S Bos","year":"2019","unstructured":"Bos S, van den Boom B, Kamphuisen PW, et al. Haemostatic profiles are similar across all aetiologies of cirrhosis. Thromb Haemost. 2019;119(2):246\u2013253","journal-title":"Thromb Haemost"},{"key":"10464_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","volume":"44","author":"G Mentha","year":"2006","unstructured":"Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari SYNDROME: a European study on 248 patients from 51 centres. J Hepatol. 2006;44:520","journal-title":"J Hepatol"},{"issue":"2","key":"10464_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/lt.21282","volume":"14","author":"F Ulrich","year":"2008","unstructured":"Ulrich F, Pratschke J, Neumann U, et al. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl. 2008;14(2):144\u2013150","journal-title":"Liver Transpl"},{"key":"10464_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/aja.1000900104","volume":"90","author":"H Elias","year":"1952","unstructured":"Elias H, Petty D. Gross anatomy of the blood vessels and ducts within the human liver. Am J Anat. 1952;90:59\u2013111","journal-title":"Am J Anat"},{"key":"10464_CR36","volume-title":"Gray\u2019s anatomy","author":"PL Williams","year":"1995","unstructured":"Williams PL, Warwick R, Dyson M, Bannister LH. Gray\u2019s anatomy. London: Churchill Livingstone; 1995"},{"key":"10464_CR37","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.ultrasmedbio.2015.03.023","volume":"41","author":"SF Cai","year":"2015","unstructured":"Cai SF, Gai YH, Ma S, Liang B, Wang GC, Liu QW. Ultrasonographic visualization of accessory hepatic veins and their lesions in Budd-Chiari syndrome. Ultrasound Med Biol. 2015;41:2091\u20132098","journal-title":"Ultrasound Med Biol"},{"key":"10464_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/SLE.0000000000000624","volume":"29","author":"F Yang","year":"2019","unstructured":"Yang F, Huang PC, Yan LL, Zhang ZD, Fu YF, Xia FF. Catheter aspiration with recanalization for Budd-Chiari syndrome with inferior vena cava thrombosis. Surg Laparosc Endosc Percutan Tech. 2019;29:304\u2013307","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10464_CR39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jvir.2010.03.008","volume":"21","author":"T Mammen","year":"2010","unstructured":"Mammen T, Keshava S, Eapen CE, Moses V, Babu NR, Kurien G, et al. Intrahepatic collateral recanalization in symptomatic Budd-Chiari syndrome: a single-center experience. J Vasc Interv Radiol. 2010;21:1119\u20131124","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"10464_CR40","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1007\/s00261-021-02977-1","volume":"46","author":"LL Lv","year":"2021","unstructured":"Lv LL, Zhu LL, Chen GH, Xu P, Xu K. Recanalization of accessory hepatic vein for hepatic vein-type Budd-Chiari syndrome. Abdom Radiol (NY). 2021;46(7):3456\u20133463","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10464_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1055\/s-0038-1661372","volume":"38","author":"S Piano","year":"2018","unstructured":"Piano S, Brocca A, Angeli P. Renal function in cirrhosis: a critical review of available tools. Semin Liver Dis. 2018;38(3):230\u2013241","journal-title":"Semin Liver Dis"},{"issue":"10","key":"10464_CR42","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00277-020-04214-z","volume":"99","author":"W F\u00fcreder","year":"2020","unstructured":"F\u00fcreder W, Sperr WR, Heibl S, et al. Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network. Ann Hematol. 2020;99(10):2303\u20132313","journal-title":"Ann Hematol"},{"issue":"5","key":"10464_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/annonc\/mdm595","volume":"19","author":"F Wimazal","year":"2008","unstructured":"Wimazal F, Sperr WR, Kundi M, et al. Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Ann Oncol. 2008;19(5):970\u2013976","journal-title":"Ann Oncol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10464-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T13:15:36Z","timestamp":1675516536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10464-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10464"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10464-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2073408\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Zhongkai Wang, Ziwei Wang, Zhiyuan Zhang, Jiandong Li, Zhiyang Pan, Ang Liu, Jian Lu, Jinhe Guo, Maoheng Zu, and Hao Xu declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We conducted a single-center, retrospective cohort study approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (Jiangsu, China; XYFY2019-KL173-01). All procedures were performed according to the Helsinki Declaration of 1975.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All enrolled patients gave written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}